Where can I learn more about this study?
You can find more information about this study on the websites listed below.
When a full report of the study results is available, it can also be found here.
X www.clinicaltrials.gov. Once you are on the website, type “NCT02337829”
into the search box and click “Search”.
X www.AstraZenecaClinicalTrials.com. Once you are on the website, type
“15-H-0016” into the search box and click “Find a Study”.
Full Study Title: A Phase II Study Using ACP-196 (Acalabrutinib) in Patients
with Relapsed/Refractory and Treatment-naïve Deletion 17p CLL/SLL:
Pharmacodynamic Assessment of BTK Inhibition and Anti-Tumor Response
AstraZeneca Protocol Number: 15-H-0016
National Clinical Trials Number: NCT02337829
Acerta Pharma BV, a member of AstraZeneca group of companies sponsored
this study and has its headquarters at Cambridge, United Kingdom.
The phone number for the AstraZeneca Information Center is +1-877-240-9479.
Thank you
Clinical study participants belong to a large community of people who take
part in clinical research around the world. They help researchers answer
important health questions and find medical treatments for patients.
The Center for Information & Study on Clinical Research Participation (CISCRP) is a non-profit organization
focused on educating and informing the public about clinical research participation. CISCRP is not involved in
recruiting participants for clinical studies, nor is it involved in conducting clinical studies.
CISCRP | One Liberty Square, Suite 1100 • Boston, MA 02109 | 1-877-MED-HERO | www.ciscrp.org
Version 2.0 2022_05_03
16 | Clinical Study Results